Marimed (MRMD) Revenue (2011 - 2026)

Marimed (MRMD) has 16 years of Revenue data on file, last reported at $39.5 million in Q1 2026.

• Revenue for Q1 2026 came in at $39.5 million, up 4.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $161.5 million (up 2.29% YoY), and the FY2025 annual result was $159.8 million, up 1.34% from the prior year.
• Revenue retreated to $39.5 million in Q1 2026 per MRMD's latest filing, from $41.6 million in the prior quarter.
• Over five years, Revenue peaked at $41.6 million in Q4 2025 and troughed at $31.3 million in Q1 2022.
• A 5-year average of $37.6 million and a median of $38.8 million in 2023 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2025: Revenue increased 26.94% in 2022, then fell 2.05% in 2025.
• A 5-year view of Revenue shows it stood at $35.8 million in 2022, then gained by 8.57% to $38.9 million in 2023, then increased by 0.13% to $38.9 million in 2024, then climbed by 6.93% to $41.6 million in 2025, then retreated by 5.21% to $39.5 million in 2026.
• Business Quant data shows MRMD's Revenue at $39.5 million in Q1 2026, $41.6 million in Q4 2025, and $40.8 million in Q3 2025.